Physician profile
Glenn E Jennings
NPI 1336196898
$896.08
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $329 · 2021: $332.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $153.33 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $131.56 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $101.84 | 2019-2021 | |
| Adlon Therapeutics L.P. | $59.48 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $56.32 | 2020-2021 | |
| Allergan, INC. | $50.02 | 2020 | |
| Janssen Pharmaceuticals, INC | $45.53 | 2019-2020 | |
| Abbvie INC. | $43.39 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.71 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.00 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $27.56 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $25.52 | 2021 | |
| Eisai INC. | $25.44 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $24.90 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $18.85 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $18.11 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.62 | 2021 | |
| Lundbeck LLC | $13.44 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.38 | 2019 | |
| Merck Sharp & Dohme LLC | $11.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Jennings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.